Trials / Conditions / CD30+ Peripheral T-cell Lymphoma
CD30+ Peripheral T-cell Lymphoma
3 registered clinical trials studyying CD30+ Peripheral T-cell Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | CD30 CAR-T in the Treatment of CD30 Positive Lymphoma NCT07048353 | Shandong Qilu Cell Therapy Engineering Technology Co., Ltd | EARLY_Phase 1 |
| Recruiting | Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients NCT07074457 | The First Affiliated Hospital of Soochow University | N/A |
| Withdrawn | Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large NCT03205891 | M.D. Anderson Cancer Center | Phase 1 |